
Opinion|Videos|March 26, 2024
Treatment Decision-Making for Newly Diagnosed Metastatic Prostate Cancer
Author(s)Matthew Smith, MD, PhD, Brian Helfand, MD, PhD
Two prostate cancer experts discuss treatment decision-making practices for patients with newly diagnosed metastatic disease.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Experts discuss the challenge of detecting CIS in bladder cancer
2
Study shows durable 3-year outcomes with first-line gemcitabine/docetaxel in NMIBC
3
Phase 3 trial launches of CAIX-targeted radiopharmaceutical for ccRCC
4
Kathryn Gessner, MD, PhD, on the challenges of selecting patients for bladder preservation
5













